Market Cap: $36.15B
Market Cap: $36.15B
Open
$68.65
Prev. Close
$74.11
High
$68.79
Low
$67.79
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide.
Alcon Inc. trades on the New York Stock Exchange under the ticker ALC, priced in USD.
Alcon Inc. has a market capitalisation of $36.15B, based on its latest share price.
ALC trades at 53.72 times its trailing 12-month earnings.
Over the past 52 weeks ALC has traded between $61.84 and $87.64.
Yes. Alcon Inc.'s dividend yields 0.51% at the current share price, paying out 26% of its earnings.
Profitable, with a net margin of 5.9% over the last 12 months.
The analyst consensus rating for ALC is Buy. Analysts' average 12-month price target of $79.58 implies 6% upside.
David J. Endicott is the CEO of Alcon Inc., which is headquartered in Geneva.
Generated automatically from reported financial data. General information only, not financial advice.
Alcon Positioned for Growth Amid Anticipated Product Launches In a significant development for Alcon, Bank of America has upgraded the company to a "buy" rating, projecting an accelerated earnings cyc…
Innovative Integration of AI in Financial Journalism: Alcon’s Strategic Alignment In an era where technology reshapes industries, Alcon stands at the forefront of innovation within the healthcare sect…
Innovating Financial Journalism: The Role of AI in Content Creation In the evolving landscape of financial journalism, the integration of artificial intelligence (AI) tools into the content creation p…
Alcon Laboratories Issues Recall for Systane Ultra PF Eye Drops Amid Food Safety Concerns In a significant move reflecting the growing scrutiny of product safety, Alcon Laboratories, a leader in eye c…